Position in ANAB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,100,317
+$363,368 QoQ
Shares Held
16,301
-18.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 211 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. ANAB ranks #117 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in ANAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,100,317 | 16,301 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $736,949 | 13,288 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $955,731 | 19,714 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,042,055 | 34,032 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $528,159 | 23,791 | Shares | Other | 2025-08-13 | |
| 2024-12-31 | $75,440 | 5,698 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $11,322 | 338 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $145,096 | 5,790 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $183,468 | 8,147 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $182,861 | 8,537 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $290,950 | 16,200 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $347,975 | 17,108 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $367,569 | 16,892 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $31,547 | 1,018 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $25,969 | 1,018 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $350,011 | 17,242 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $425,452 | 17,197 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $622,651 | 17,918 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $498,709 | 18,389 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $461,579 | 17,801 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $383,611 | 17,801 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $443,027 | 20,606 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $604,775 | 41,002 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $510,064 | 22,832 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $601,556 | 42,573 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||